Delcath Systems ROE 2010-2025 | DCTH
Current and historical return on equity (ROE) values for Delcath Systems (DCTH) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Delcath Systems ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $-0.01B | $0.08B | -34.57% |
| 2024-12-31 | $-0.03B | $0.07B | -107.22% |
| 2024-09-30 | $-0.03B | $0.01B | -309.09% |
| 2024-06-30 | $-0.06B | $0.00B | -373.33% |
| 2024-03-31 | $-0.05B | $0.02B | -350.00% |
| 2023-12-31 | $-0.05B | $0.02B | -671.43% |
| 2023-09-30 | $-0.04B | $0.03B | -2933.33% |
| 2023-06-30 | $-0.03B | $0.00B | 550.00% |
| 2023-03-31 | $-0.04B | $-0.01B | 533.33% |
| 2022-12-31 | $-0.04B | $-0.01B | 1600.00% |
| 2022-09-30 | $-0.03B | $-0.01B | -1466.67% |
| 2022-06-30 | $-0.03B | $0.00B | -476.92% |
| 2022-03-31 | $-0.03B | $0.01B | -245.45% |
| 2021-12-31 | $-0.03B | $0.01B | -169.49% |
| 2021-09-30 | $-0.03B | $0.01B | -156.52% |
| 2021-06-30 | $-0.03B | $0.02B | -166.67% |
| 2021-03-31 | $-0.02B | $0.02B | -173.58% |
| 2020-12-31 | $-0.02B | $0.02B | -384.00% |
| 2020-09-30 | $-0.01B | $0.00B | 666.67% |
| 2020-06-30 | $-0.01B | $0.01B | 128.00% |
| 2020-03-31 | $-0.01B | $-0.01B | 63.49% |
| 2019-12-31 | $-0.01B | $-0.01B | 50.63% |
| 2019-09-30 | $-0.03B | $-0.02B | 150.00% |
| 2019-06-30 | $-0.03B | $-0.03B | 183.78% |
| 2019-03-31 | $-0.04B | $-0.02B | 245.61% |
| 2018-12-31 | $-0.02B | $-0.02B | 205.13% |
| 2018-09-30 | $-0.03B | $-0.01B | 504.35% |
| 2018-06-30 | $-0.03B | $-0.01B | 660.00% |
| 2018-03-31 | $-0.03B | $-0.01B | 1866.67% |
| 2017-12-31 | $-0.05B | $0.00B | 18400.00% |
| 2017-09-30 | $-0.03B | $0.00B | 4533.33% |
| 2017-06-30 | $-0.02B | $0.00B | -2933.33% |
| 2017-03-31 | $-0.03B | $0.00B | -1542.86% |
| 2016-12-31 | $-0.02B | $0.00B | -450.00% |
| 2016-09-30 | $-0.02B | $0.00B | -230.77% |
| 2016-06-30 | $-0.02B | $0.01B | -177.78% |
| 2016-03-31 | $-0.01B | $0.01B | -118.18% |
| 2015-12-31 | $-0.01B | $0.01B | -107.69% |
| 2015-09-30 | $-0.01B | $0.01B | -78.69% |
| 2015-06-30 | $-0.02B | $0.01B | -88.24% |
| 2015-03-31 | $-0.02B | $0.02B | -80.00% |
| 2014-12-31 | $-0.02B | $0.02B | -76.60% |
| 2014-09-30 | $-0.02B | $0.02B | -75.47% |
| 2014-06-30 | $-0.02B | $0.03B | -77.88% |
| 2014-03-31 | $-0.02B | $0.03B | -72.73% |
| 2013-12-31 | $-0.03B | $0.03B | -93.02% |
| 2013-09-30 | $-0.04B | $0.03B | -121.01% |
| 2013-06-30 | $-0.04B | $0.03B | -141.38% |
| 2013-03-31 | $-0.05B | $0.04B | -194.29% |
| 2012-12-31 | $-0.05B | $0.02B | -252.38% |
| 2012-09-30 | $-0.06B | $0.03B | -253.33% |
| 2012-06-30 | $-0.05B | $0.02B | -201.90% |
| 2012-03-31 | $-0.04B | $0.02B | -160.75% |
| 2011-12-31 | $-0.03B | $0.03B | -100.84% |
| 2011-09-30 | $-0.03B | $0.04B | -98.36% |
| 2011-06-30 | $-0.03B | $0.02B | -103.23% |
| 2011-03-31 | $-0.04B | $0.03B | -120.69% |
| 2010-12-31 | $-0.05B | $0.03B | -191.84% |
| 2010-09-30 | $-0.04B | $0.04B | -163.44% |
| 2010-06-30 | $-0.04B | $0.02B | -313.04% |
| 2010-03-31 | $-0.03B | $0.01B | -425.00% |
| 2009-12-31 | $-0.02B | $0.02B | -303.45% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.588B | $0.037B |
| Delcath Systems, Inc. has developed a system, the Delcath system, to isolate the liver from the general circulatory system and to administer chemotherapy and other therapeutic agents directly to the liver. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $200.019B | 87.61 |
| Thermo Fisher Scientific (TMO) | United States | $150.378B | 18.19 |
| Edwards Lifesciences (EW) | United States | $45.620B | 29.91 |
| Alcon (ALC) | Switzerland | $42.878B | 28.98 |
| IDEXX Laboratories (IDXX) | United States | $41.997B | 48.26 |
| DexCom (DXCM) | United States | $33.619B | 51.96 |
| IQVIA Holdings (IQV) | United States | $25.495B | 14.28 |
| Mettler-Toledo (MTD) | United States | $24.204B | 28.78 |
| STERIS (STE) | Ireland | $23.962B | 26.39 |
| Waters (WAT) | United States | $20.610B | 29.08 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.452B | 0.00 |
| Hologic (HOLX) | United States | $14.055B | 15.27 |
| Sysmex ADR (SSMXY) | Japan | $10.248B | 29.07 |
| Penumbra (PEN) | United States | $10.006B | 78.54 |
| Masimo (MASI) | United States | $8.931B | 32.94 |
| Globus Medical (GMED) | United States | $8.062B | 19.21 |
| Teleflex (TFX) | United States | $5.411B | 8.93 |
| Glaukos (GKOS) | United States | $5.296B | 0.00 |
| TransMedics (TMDX) | United States | $4.586B | 99.70 |
| Integer Holdings (ITGR) | United States | $4.218B | 22.10 |
| PROCEPT BioRobotics (PRCT) | United States | $3.599B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.445B | 14.56 |
| Nihon Kohden (NHNKY) | Japan | $2.253B | 25.84 |
| Veracyte (VCYT) | United States | $2.113B | 29.65 |
| Elekta AB (EKTAY) | Sweden | $1.973B | 17.74 |
| Alphatec Holdings (ATEC) | United States | $1.818B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.376B | 0.00 |
| Artivion (AORT) | United States | $1.244B | 116.48 |
| Pulse Biosciences (PLSE) | United States | $1.098B | 0.00 |
| OPKO Health (OPK) | United States | $1.086B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.033B | 5.49 |
| Beta Bionics (BBNX) | United States | $0.848B | 0.00 |
| SiBone (SIBN) | United States | $0.812B | 0.00 |
| IRadimed (IRMD) | United States | $0.767B | 38.94 |
| RxSight (RXST) | United States | $0.606B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.570B | 8.87 |
| Mesa Laboratories (MLAB) | United States | $0.544B | 12.76 |
| OrthoPediatrics (KIDS) | United States | $0.507B | 0.00 |
| AxoGen (AXGN) | United States | $0.492B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.445B | 0.00 |
| NeuroPace (NPCE) | United States | $0.436B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.420B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.364B | 9.69 |
| Treace Medical Concepts (TMCI) | United States | $0.363B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.359B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.300B | 0.00 |
| Neuronetics (STIM) | United States | $0.252B | 0.00 |
| 908 Devices (MASS) | United States | $0.240B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.235B | 14.24 |
| Sight Sciences (SGHT) | United States | $0.217B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.198B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.179B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| Inogen (INGN) | United States | $0.169B | 0.00 |
| CVRx (CVRX) | United States | $0.168B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.157B | 0.00 |
| Accuray (ARAY) | United States | $0.157B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.155B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.131B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.111B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.090B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.083B | 50.30 |
| InspireMD (NSPR) | United States | $0.077B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.068B | 0.00 |
| Hyperfine (HYPR) | United States | $0.067B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.061B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| Spectral AI (MDAI) | United States | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.028B | 0.00 | |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.37 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |